Prevalence of factor V Leiden and prothrombin variant G20210A in patients age < 50 years with no significant stenoses at angiography three to four weeks after myocardial infarction
Ns. Van De Water et al., Prevalence of factor V Leiden and prothrombin variant G20210A in patients age < 50 years with no significant stenoses at angiography three to four weeks after myocardial infarction, J AM COL C, 36(3), 2000, pp. 717-722
Citations number
39
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
OBJECTIVES We sought to determine the frequencies of factor V Leiden and pr
othrombin variant G20210A in patients age <50 years with no significant cor
onary stenoses three to four weeks after myocardial infarction (MI).
BACKGROUND Factor V Leiden and prothrombin variant G20210A occur frequently
in patients with venous thromboembolism. However, the contribution of thes
e mutations to the development of MI requires clarification.
METHODS The frequencies of factor V Leiden and prothrombin variant G20210A
were determined in 41 patients age <50 years who had "normal" or "near norm
al" coronary arteries (no stenosis >50%) at angiography three to four weeks
after MI (the study group) and compared with these in 114 patients who had
at least one angiographic stenosis >50% after MI (the control group). Pati
ents age greater than or equal to 50 years with, or without, stenoses were
also studied.
RESULTS The frequency of factor V Leiden was 14.6% in patients age <50 year
s in the study group compared with 3.6% in patients in the control group (o
dds ratio [OR] 4.7 [95% confidence interval (CI) 1.3-17.7], p = 0.02). The
frequency of the prothrombin variant G20210A was 7.3% in the study group co
mpared with 1.8% in the control group (OR 4.3 [95% CI 0.7-27.5], p = 0.12).
One or both mutations were present in 8 of the 41 patients (19.5%) age <50
years in the study group compared with 6 of the 114 patients (5.5%) in the
control group (OR 4.3 [95% CI 1.4-13.5], p = 0.01). In all 271 patients (i
rrespective of age) with normal arteries, the frequency of factor V Leiden
was 11.7% (7/60) compared with 4.3% (9/211) in patients with at least one >
50% stenosis (OR 2.9 [95% CI 1.1-8.3], p = 0.04), and the frequency of prot
hrombin variant G20210A was 6.7% (4/60) compared with 1.4% (3/211) (OR 4.9
[95% CI 1.1-22.8], p = 0.04), respectively.
CONCLUSION The frequencies of factor V Leiden and/or prothrombin variant G2
0210A are increased in patients age <50 years with normal or near normal co
ronary arteries after MI. (C) 2000 by the American College of Cardiology.